User:Letícia Oliveira Rojas Cruz/Sandbox 1
From Proteopedia
< User:Letícia Oliveira Rojas Cruz(Difference between revisions)
Line 1: | Line 1: | ||
- | ==Angiotensin-converting enzyme 2 (ACE2)-(PDB 1R42)== | + | ==Angiotensin-converting enzyme 2 (ACE2) - (PDB 1R42)== |
<StructureSection load='6m17' size='425' side='right' caption='PDB 6m17' scene='10/1083732/Ace2_completa/3'> | <StructureSection load='6m17' size='425' side='right' caption='PDB 6m17' scene='10/1083732/Ace2_completa/3'> | ||
<scene name='10/1083732/Ace2_completa/3'>Angiotensin-converting enzyme 2 (ACE2)</scene> is an important protein expressed in several human tissues, such as the heart and kidneys. It plays a key role in the Renin-Angiotensin-Aldosterone System - "RAAS" - by catalyzing the conversion of angiotensin II (Ang II), promoting blood pressure regulation. | <scene name='10/1083732/Ace2_completa/3'>Angiotensin-converting enzyme 2 (ACE2)</scene> is an important protein expressed in several human tissues, such as the heart and kidneys. It plays a key role in the Renin-Angiotensin-Aldosterone System - "RAAS" - by catalyzing the conversion of angiotensin II (Ang II), promoting blood pressure regulation. | ||
Line 24: | Line 24: | ||
The Renin-Angiotensin-Aldosterone System - "RAAS" -, in which ACE2 acts, is an important signaling pathway responsible for vascular homeostasis. | The Renin-Angiotensin-Aldosterone System - "RAAS" -, in which ACE2 acts, is an important signaling pathway responsible for vascular homeostasis. | ||
In general, Ang II, generated by the action of ACE on Ang I, and this one by the action of Renin on Angiotensinogen, acts on AT1 and AT2 receptors. Its main action is vasoconstriction (by AT1 receptor), increasing blood pressure. On the other hand, Angiotensin (1-7), generated from Ang II by ACE2, has the opposite function, leading to a decline in blood pressure through vasodilation and release of Nitric Oxide (NO) through its action on the MAS oncogene receptor, antagonizing the actions of Ang II. <ref>PMID:19461648</ref> | In general, Ang II, generated by the action of ACE on Ang I, and this one by the action of Renin on Angiotensinogen, acts on AT1 and AT2 receptors. Its main action is vasoconstriction (by AT1 receptor), increasing blood pressure. On the other hand, Angiotensin (1-7), generated from Ang II by ACE2, has the opposite function, leading to a decline in blood pressure through vasodilation and release of Nitric Oxide (NO) through its action on the MAS oncogene receptor, antagonizing the actions of Ang II. <ref>PMID:19461648</ref> | ||
+ | |||
+ | [[Image:RAAS.png|350px]] <ref>PMID:33389262</ref> | ||
== Pathological Relevance == | == Pathological Relevance == |
Current revision
Angiotensin-converting enzyme 2 (ACE2) - (PDB 1R42)
|
References
- ↑ Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919. PMID:33389262 doi:10.1007/s10096-020-04138-6
- ↑ Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem Pharmacol. 2008 Feb 15;75(4):781-6. PMID:17897633 doi:10.1016/j.bcp.2007.08.012
- ↑ Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009 Jul;32(7):533-6. PMID:19461648 doi:10.1038/hr.2009.74
- ↑ Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919. PMID:33389262 doi:10.1007/s10096-020-04138-6
- ↑ Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020, Mar 5. PMID:32142651 doi:http://dx.doi.org/10.1016/j.cell.2020.02.052
- ↑ Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:http://dx.doi.org/10.1126/science.abb2762
OUDIT, G. Y. et al. Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic. Cell, v. 186, n. 5, p. 906–922, mar. 2023.